Immunotherapy and Liver Transplantation The Future or the Failure?

被引:7
作者
Tabrizian, Parissa [1 ]
Yu, Allen [1 ]
Debnath, Neha [1 ]
Myers, Bryan [1 ]
Marron, Thomas [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, Liver Transplant & Hepatobiliary Surg, One Gustave L Levy, New York, NY 10029 USA
关键词
Liver transplantation; Hepatocellular carcinoma; Immunotherapy; Rejection; Outcomes; RESECTABLE HEPATOCELLULAR-CARCINOMA; ATEZOLIZUMAB PLUS BEVACIZUMAB; NEOADJUVANT THERAPY; OPEN-LABEL; PHASE-III; TRIAL; RISK; PEMBROLIZUMAB; NIVOLUMAB; ADJUVANT;
D O I
10.1016/j.suc.2023.07.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
center dot The increasing demand for liver transplantation (LT) for hepatocellular carcinoma (HCC) has led to the continued efforts to expand LT indications.center dot Immunotherapy has revolutionized the treatment of advanced HCC over the past few years.center dot HCC and other solid tumors exploit evolutionary conserved inhibitory immune checkpoints to evade antitumor immune response by upregulating cognate ligands or receptors capable of inhibiting antitumor immunity.
引用
收藏
页码:163 / 182
页数:20
相关论文
共 75 条
[1]   Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report [J].
Abdelrahim, Maen ;
Esmail, Abdullah ;
Umoru, Godsfavour ;
Westhart, Kiersten ;
Abudayyeh, Ala ;
Saharia, Ashish ;
Ghobrial, Rafik M. .
CURRENT ONCOLOGY, 2022, 29 (06) :4267-4273
[2]   Complications of Living Donor Hepatic Lobectomy-A Comprehensive Report [J].
Abecassis, M. M. ;
Fisher, R. A. ;
Olthoff, K. M. ;
Freise, C. E. ;
Rodrigo, D. R. ;
Samstein, B. ;
Kam, I. ;
Merion, R. M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) :1208-1217
[3]  
Abou-Alfa GK, 2022, NEJM EVID, V1, DOI 10.1056/EVIDoa2100070
[4]   Immune Checkpoint Inhibitor Therapy Before Liver Transplantation-Case and Literature Review [J].
Aby, Elizabeth S. ;
Lake, John R. .
TRANSPLANTATION DIRECT, 2022, 8 (04) :E1304
[5]   Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases [J].
Al Jarroudi, Ouissam ;
Ulusakarya, Ayhan ;
Almohamad, Wathek ;
Afqir, Said ;
Morere, Jean-Francois .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
[6]   Successful Treatment of Disseminated Hepatocellular Carcinoma After Liver Transplantation With Nivolumab [J].
Amjad, Waseem ;
Kotiah, Sandy ;
Gupta, Ankur ;
Morris, Michael ;
Liu, Li ;
Thuluvath, Paul J. .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (02) :185-187
[7]   Nivolumab-Induced Autoimmune-Like Cholestatic Hepatitis in a Liver Transplant Recipient [J].
Anugwom, Chimaobi ;
Leventhal, Thomas .
ACG CASE REPORTS JOURNAL, 2020, 7 (07)
[8]   CAPT: A multicenter randomized controlled trial of perioperative versus postoperative camrelizumab plus apatinib for resectable hepatocellular carcinoma [J].
Bai, X. ;
Chen, Y. ;
Zhang, X. ;
Zhang, F. ;
Liang, X. ;
Zhang, C. ;
Wang, X. ;
Lu, B. ;
Yu, S. ;
Liang, T. .
ANNALS OF ONCOLOGY, 2022, 33 (07) :S868-S868
[9]   The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes [J].
Bittermann, Therese ;
Hubbard, Rebecca A. ;
Lewis, James D. ;
Goldberg, David S. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (12) :3319-3327
[10]   Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma [J].
Blank, Christian U. ;
Rozeman, Elisa A. ;
Fanchi, Lorenzo F. ;
Sikorska, Karolina ;
van de Wiel, Bart ;
Kvistborg, Pia ;
Krijgsman, Oscar ;
van den Braber, Marlous ;
Philips, Daisy ;
Broeks, Annegien ;
van Thienen, Johannes, V ;
Mallo, Henk A. ;
Adriaansz, Sandra ;
ter Meulens, Sylvia ;
Pronk, Loes M. ;
Grijpink-Ongering, Lindsay G. ;
Bruining, Annemarie ;
Gittelman, Rachel M. ;
Warren, Sarah ;
van Tinteren, Harm ;
Peeper, Daniel S. ;
Haanen, John B. A. G. ;
van Akkooi, Alexander C. J. ;
Schumacher, Ton N. .
NATURE MEDICINE, 2018, 24 (11) :1655-+